Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
March 2006
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
Saskatchewan Winters Last updated: Mon 04 Feb 2008 11:19 PM CST
Saskatchewan Blizzard
View Article  Tovaxin to be presented by PharmaFrontiers
PharmaFrontiers Corp, a company involved in the development and commercialization of cell therapies, announced today that its paper entitled, "Autologous Trivalent T Cell Therapy in Multiple Sclerosis: A Study of Patients Previously Treated with   more »
View Article  Muscle Repair: Making A Good System Better And Faster
Skeletal muscles naturally repair themselves very efficiently after injury. But when they don't, otherwise successful recovery following damage from overuse during exercise, surgery or trauma can be stymied. Furthermore, as we age, muscle repair slows noticeably, and in Duchenne Muscular Dystrophy and other degenerative muscle diseases, normal repair functions can't cope with   more »
View Article  Is incontinence an MS factor? What therapy is recommended?
Q Is incontinence an MS factor? What therapy is recommended?
A

People with MS can certainly suffer from incontinence. This really needs to be investigated ...   more »

View Article  Living Well With MS: Mind Matters

New Publication on Depression: Living Well With MS: Mind Matters

 

 

A new publication is now available in the MSUniversityTM library! 

This booklet ...   more »
View Article  Hopes Raised For Effectiveness Of MS Drug
Discovery of the mechanism of a drug being tested for the treatment of multiple sclerosis (MS) has revealed that it's not only more effective than   more »
View Article  When the Body Reacts Against Multiple Sclerosis Drugs
Some drugs for multiple sclerosis may cause a natural immune reaction that makes the disease harder to treat. How do you get by your body's own defenses to   more »
View Article  Patients Want More Access to Treatments
A new report issued today by the National Consumers League (NCL) has found that the American public strongly supports broader access to treatments -- even if they carry additional risks - - for patients suffering from chronic, debilitating conditions such as Multiple Sclerosis, Parkinson's and   more »
View Article  Protein Fragment May Generate First Simple Test For MS
Johns Hopkins scientists report the discovery of a protein found only in cerebrospinal fluid that they say might be useful in identifying a subgroup of patients with multiple sclerosis (MS) or identifying those at risk for   more »
View Article  Treatment with Glatiramer Acetate Linked to Greater Disease Stability
Patients with early-onset multiple sclerosis have increased disease stability and fewer rates of disease progression when they are treated with glatiramer acetate (Copaxone), according to findings presented here 15th meeting of the European Neurological Society (ENS). "The results confirm the benefit seen in   more »
View Article  MS research into reparative cells offers new avenue for fighting MS
Plaques that form around the nerve cells of people with multiple sclerosis are apparently what disable people with the disease. But partly developed reparative cells within the plaques provide hope for a treatment, a   more »
View Article  MS CyberWatch is now available!

MS CyberWatch is now available! This interactive newsletter will keep you well connected with the Cyber world of MS. This tool gives you an update ...   more »

View Article  video - Making a Plan for MS: Why Start Treatment?
video - treatment   more »
View Article  Anatomy of MS
In MS, inflammatory lesions develop in the central nervous system. But how does this process produce the symptoms that you feel? The editor's article features the anatomy of MS and explains the different parts of the brain and how they may be affected by MS.   more »
View Article  MS Treatment: Is It Ever Too Soon?
When I discuss treatment options with patients, I discuss specific issues to help them work with me on deciding which drug they're going to be taking. We look at efficacy of the medications with regard to relapse rate and MRI data. We look at the patient's disability and cognitive function. We look at quality of life. For example, which medication   more »
View Article  Abatacept May Reduce Disease Activity

Higher Doses of Abatacept May Reduce Disease Activity in Relapsing-Remitting Multiple Sclerosis


VIENNA, AUSTRIA

 

Patients with relapsing-remitting multiple sclerosis appear to have fewer lesions ...   more »